BIONXT SOLUTIONS INC.

Insiders BioNxt Solutions Inc.

Equities

BNXT

CA0909741062

Market Closed - Canadian Securities Exchange Other stock markets 11:14:03 2024-04-26 am EDT			5-day change	1st Jan Change
0.4 ^CAD	0.00%		+1.27%	-17.53%

Apr. 26	BioNxt Solutions Inc. Announces ODF Cladribine Update	CI
Apr. 26	BioNxt Solutions Inc. announced that it expects to receive CAD 1.62 million in funding	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BioNxt Solutions Inc. Announces Change of Directors	23-10-03	CI
XPhyto Therapeutics Corp. will Change its Name to BioNxt Solutions Inc	22-11-14	CI
Xphyto Therapeutics Corp. Adds Dr. Flon A. Sahr to Its European Teateam as Head of Project Management	22-06-08	CI
XPhyto Therapeutics Corp. Appoints Drahoslav Zdarek as the Company's Head of Sales, Europe	22-01-17	CI
XPhyto Therapeutics Corp. Announces Executive Appointments	22-01-10	CI
XPhyto Therapeutics Corp. Announces Management Changes	21-11-03	CI
XPhyto Therapeutics Corp. Appoints Wolfgang Probst as the Chief Operations Officer	21-04-21	CI
XPhyto Therapeutics Corp. Appoints Per S. Thoresen to the Board of Directors	20-11-04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer